Abstrax Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 90

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Abstrax General Information

Description

Operator of a cannabis research company intended to focus on the study of botanical and cannabis-derived functional flavors and fragrances. The company offers the largest terpene catalog of the most popular strains, botanically-derived terpene blends, and isolates native to cannabis used in vapes, enabling businesses in the food, beverage, cannabis, and wellness industries to access ultra-pure, customizable compounds for product formulation, consistent sensory experiences, and regulatory compliance, while supporting innovation and differentiation in competitive consumer markets.

Contact Information

Website
abstraxtech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1672 Reynolds Avenue
  • Irvine, CA 92614
  • United States
+1 (562)
Primary Industry
Other Consumer Non-Durables
Corporate Office
  • 1672 Reynolds Avenue
  • Irvine, CA 92614
  • United States
+1 (562)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abstrax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Oct-2022 Completed Generating Revenue
3. Early Stage VC (Series A) 14-Jan-2021 Cancelled Generating Revenue
2. Early Stage VC 01-Jan-2020 $1M $2M Completed Startup
1. Angel (individual) $1M $1M Completed Startup
To view Abstrax’s complete valuation and funding history, request access »

Abstrax Patents

Abstrax Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260240874-A1 Prenylated cannabinoids and their derivatives for the treatment of cancer Pending 14-Feb-2025
US-20260123653-A1 Foam enhancing phospholipid emulsion systems Pending 06-Nov-2024
WO-2026102053-A1 Foam enhancing phospholipid emulsion systems Pending 06-Nov-2024
US-20260123645-A1 Gum acacia-free and weighting agent-free emulsions Pending 06-Nov-2024
WO-2026102046-A1 Gum acacia-free and weighting agent-free emulsions Pending 06-Nov-2024 A23D7/011
To view Abstrax’s complete patent history, request access »

Abstrax Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abstrax Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arcadian Capital Growth/Expansion Minority
Arcview Ventures Corporate Venture Capital Minority
Entourage Effect Capital Venture Capital Minority
To view Abstrax’s complete investors history, request access »

Abstrax FAQs

  • When was Abstrax founded?

    Abstrax was founded in 2017.

  • Where is Abstrax headquartered?

    Abstrax is headquartered in Irvine, CA.

  • What is the size of Abstrax?

    Abstrax has 90 total employees.

  • What industry is Abstrax in?

    Abstrax’s primary industry is Other Consumer Non-Durables.

  • Is Abstrax a private or public company?

    Abstrax is a Private company.

  • What is Abstrax’s current revenue?

    The current revenue for Abstrax is .

  • How much funding has Abstrax raised over time?

    Abstrax has raised $2M.

  • Who are Abstrax’s investors?

    Arcadian Capital, Arcview Ventures, and Entourage Effect Capital have invested in Abstrax.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process